• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对Keap1-Nrf2相互作用的细胞渗透性环肽抑制剂的研发。

Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.

作者信息

Salim Heba, Song Jian, Sahni Ashweta, Pei Dehua

机构信息

Department of Chemistry and Biochemistry , The Ohio State University , 484 West 12th Avenue , Columbus , Ohio 43210 , United States.

School of Pharmacy , Guangdong Pharmaceutical University , Guangzhou , Guangdong Province 510006 , P.R. China.

出版信息

J Org Chem. 2020 Feb 7;85(3):1416-1424. doi: 10.1021/acs.joc.9b02367. Epub 2019 Oct 28.

DOI:10.1021/acs.joc.9b02367
PMID:31609620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7288753/
Abstract

Macrocyclic peptides have proven to be highly effective inhibitors of protein-protein interactions but generally lack cell permeability to access intracellular targets. We show herein that macrocyclic peptides may be rendered highly cell-permeable and biologically active by conjugating them with a cyclic cell-penetrating peptide (CPP). A previously reported cyclic peptidyl inhibitor against the Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid-2 (Nrf2) interaction ( = 18 nM) was covalently attached to a cyclic CPP through a flexible linker. The resulting bicyclic peptide retained the Keap1-binding activity, resisted proteolytic degradation, readily entered mammalian cells, and activated the transcriptional activity of Nrf2 at nanomolar to low micromolar concentrations in cell culture. The inhibitor provides a useful tool for investigating the biological function of Keap1-Nrf2 and a potential lead for further development into a novel class of anti-inflammatory and anticancer agents. Our data suggest that other membrane-impermeable cyclic peptides may be similarly rendered cell-permeable by conjugation with a cyclic CPP.

摘要

大环肽已被证明是蛋白质-蛋白质相互作用的高效抑制剂,但通常缺乏细胞通透性以作用于细胞内靶点。我们在此表明,通过将大环肽与环状细胞穿透肽(CPP)偶联,可使其具有高度的细胞通透性和生物活性。一种先前报道的针对 Kelch 样 ECH 相关蛋白 1(Keap1)-核因子红细胞 2(Nrf2)相互作用的环状肽基抑制剂( = 18 nM)通过柔性接头共价连接到环状 CPP 上。所得的双环肽保留了 Keap1 结合活性,抵抗蛋白水解降解,易于进入哺乳动物细胞,并在细胞培养中以纳摩尔至低微摩尔浓度激活 Nrf2 的转录活性。该抑制剂为研究 Keap1-Nrf2 的生物学功能提供了有用的工具,并为进一步开发新型抗炎和抗癌药物提供了潜在的先导化合物。我们的数据表明,其他不能透过细胞膜的环状肽可能通过与环状 CPP 偶联而同样具有细胞通透性。

相似文献

1
Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.一种针对Keap1-Nrf2相互作用的细胞渗透性环肽抑制剂的研发。
J Org Chem. 2020 Feb 7;85(3):1416-1424. doi: 10.1021/acs.joc.9b02367. Epub 2019 Oct 28.
2
Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency.发现一种头对尾环肽作为具有高细胞活性的Keap1-Nrf2蛋白质-蛋白质相互作用抑制剂。
Eur J Med Chem. 2018 Jan 1;143:1578-1589. doi: 10.1016/j.ejmech.2017.10.052. Epub 2017 Oct 19.
3
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction.线性和环状肽类 KEAP1-NRF2 蛋白-蛋白相互作用抑制剂的优化。
Bioorg Med Chem. 2020 Nov 1;28(21):115738. doi: 10.1016/j.bmc.2020.115738. Epub 2020 Aug 30.
4
Cyclic Peptide Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury.环状肽 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂:设计、合成与急性肺损伤的体内治疗。
J Med Chem. 2024 Mar 28;67(6):4889-4903. doi: 10.1021/acs.jmedchem.4c00065. Epub 2024 Mar 14.
5
Recapitulating the Binding Affinity of Nrf2 for KEAP1 in a Cyclic Heptapeptide, Guided by NMR, X-ray Crystallography, and Machine Learning.通过 NMR、X 射线晶体学和机器学习指导,在环状七肽中重现 Nrf2 与 KEAP1 的结合亲和力。
J Am Chem Soc. 2021 Mar 17;143(10):3779-3793. doi: 10.1021/jacs.0c09799. Epub 2021 Mar 8.
6
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.发现一种具有天然脯氨酸结构的 Kelch 样 ECH 相关蛋白 1-核因子红细胞 2 相关因子 2(Keap1-Nrf2)蛋白-蛋白相互作用抑制剂,作为对抗对乙酰氨基酚诱导的肝毒性的细胞保护剂。
J Med Chem. 2019 Jul 25;62(14):6796-6813. doi: 10.1021/acs.jmedchem.9b00818. Epub 2019 Jul 17.
7
Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction.基于全氟芳烃的肽大环化合物,可抑制Nrf2/Keap1相互作用。
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2728-2731. doi: 10.1016/j.bmcl.2018.03.003. Epub 2018 Mar 3.
8
Computational Prediction of Cyclic Peptide Structural Ensembles and Application to the Design of Keap1 Binders.计算预测环状肽结构集合及其在 Keap1 结合物设计中的应用。
J Chem Inf Model. 2023 Nov 13;63(21):6925-6937. doi: 10.1021/acs.jcim.3c01337. Epub 2023 Nov 2.
9
Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.发现 2-氧代-2-苯基乙酸取代的萘磺酰胺衍生物作为有效的 KEAP1-NRF2 蛋白-蛋白相互作用抑制剂,用于炎症情况。
Eur J Med Chem. 2020 Dec 1;207:112734. doi: 10.1016/j.ejmech.2020.112734. Epub 2020 Aug 22.
10
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.单酸型 Kelch 样 ECH 相关蛋白 1:核因子红细胞 2 相关因子 2(KEAP1:NRF2)蛋白-蛋白相互作用抑制剂:基于片段的发现技术具有高细胞效力。
J Med Chem. 2016 Apr 28;59(8):3991-4006. doi: 10.1021/acs.jmedchem.6b00228. Epub 2016 Apr 12.

引用本文的文献

1
Computational design of diverse nuclear factor erythroid 2 activators with cellular antioxidative activity.具有细胞抗氧化活性的多种核因子红细胞2激活剂的计算设计。
iScience. 2025 May 8;28(6):112621. doi: 10.1016/j.isci.2025.112621. eCollection 2025 Jun 20.
2
Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases.富马酸二甲酯的非Nrf2依赖性抗炎作用:开发用于神经退行性疾病的亲电子Nrf2激活剂所面临的挑战与前景。
Antioxidants (Basel). 2024 Dec 13;13(12):1527. doi: 10.3390/antiox13121527.
3
The backbone constitution drives passive permeability independent of side chains in depsipeptide and peptide macrocycles inspired by -verticilide.

本文引用的文献

1
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.已知小分子 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂的比较评估研究:化学合成、结合特性和细胞活性。
J Med Chem. 2019 Sep 12;62(17):8028-8052. doi: 10.1021/acs.jmedchem.9b00723. Epub 2019 Aug 27.
2
Understanding Cell Penetration of Cyclic Peptides.理解环状肽的细胞穿透性。
Chem Rev. 2019 Sep 11;119(17):10241-10287. doi: 10.1021/acs.chemrev.9b00008. Epub 2019 May 14.
3
Head to tail cyclisation of cell-penetrating peptides: impact on GAG-dependent internalisation and direct translocation.
受轮枝菌素启发的缩肽和肽大环化合物中,主链结构驱动被动渗透性,与侧链无关。
Chem Sci. 2024 Aug 15;15(36):14977-87. doi: 10.1039/d4sc02758b.
4
Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers.用类蛋白聚合物抑制 Keap1/Nrf2 蛋白-蛋白相互作用。
Adv Mater. 2024 May;36(21):e2311467. doi: 10.1002/adma.202311467. Epub 2024 Feb 16.
5
Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives.新兴的 Bach1 小分子抑制剂作为治疗药物:原理、最新进展和未来展望。
Bioessays. 2024 Jan;46(1):e2300176. doi: 10.1002/bies.202300176. Epub 2023 Nov 2.
6
A cell-active cyclic peptide targeting the Nrf2/Keap1 protein-protein interaction.一种靶向Nrf2/Keap1蛋白质-蛋白质相互作用的细胞活性环肽。
Chem Sci. 2023 Sep 20;14(39):10800-10805. doi: 10.1039/d3sc04083f. eCollection 2023 Oct 11.
7
Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.设计通过内吞作用进入细胞的细胞穿透肽疗法。
ACS Symp Ser Am Chem Soc. 2022;1417:179-197. doi: 10.1021/bk-2022-1417.ch007. Epub 2022 Aug 4.
8
KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential.KEAP1-NRF2 蛋白-蛋白相互作用抑制剂:设计、药理学特性和治疗潜力。
Med Res Rev. 2023 Jan;43(1):237-287. doi: 10.1002/med.21925. Epub 2022 Sep 10.
9
Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.发现一种具有改进的内体逃逸和细胞质递送效率的环状细胞穿透肽。
Mol Pharm. 2022 May 2;19(5):1378-1388. doi: 10.1021/acs.molpharmaceut.1c00924. Epub 2022 Apr 11.
10
Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions.界面肽作为蛋白质-蛋白质相互作用的亲和调节因子。
Biomolecules. 2022 Jan 8;12(1):106. doi: 10.3390/biom12010106.
穿膜肽的头尾环化:对 GAG 依赖性内化和直接转位的影响。
Chem Commun (Camb). 2019 Apr 11;55(31):4566-4569. doi: 10.1039/c9cc01265f.
4
Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library.可透细胞膜双环肽类抑制剂通过组合文库直接作用于 NEMO-IκB 激酶相互作用
J Am Chem Soc. 2018 Sep 26;140(38):12102-12110. doi: 10.1021/jacs.8b06738. Epub 2018 Sep 11.
5
Orally Active Peptides: Is There a Magic Bullet?口服活性肽:是否存在灵丹妙药?
Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438. doi: 10.1002/anie.201807298. Epub 2018 Oct 3.
6
Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.修饰的 Keap1-Nrf2 蛋白-蛋白相互作用的肽抑制剂,包含非天然氨基酸。
Chembiochem. 2018 Sep 4;19(17):1810-1816. doi: 10.1002/cbic.201800170. Epub 2018 Jul 18.
7
Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction.基于全氟芳烃的肽大环化合物,可抑制Nrf2/Keap1相互作用。
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2728-2731. doi: 10.1016/j.bmcl.2018.03.003. Epub 2018 Mar 3.
8
Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency.发现一种头对尾环肽作为具有高细胞活性的Keap1-Nrf2蛋白质-蛋白质相互作用抑制剂。
Eur J Med Chem. 2018 Jan 1;143:1578-1589. doi: 10.1016/j.ejmech.2017.10.052. Epub 2017 Oct 19.
9
Orally Absorbed Cyclic Peptides.口服环肽
Chem Rev. 2017 Jun 28;117(12):8094-8128. doi: 10.1021/acs.chemrev.6b00838. Epub 2017 May 25.
10
The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.Keap1-Nrf2信号通路:对抗活性氧介导的癌症和神经退行性疾病损伤的潜在治疗靶点。
Biophys Rev. 2017 Feb;9(1):41-56. doi: 10.1007/s12551-016-0244-4. Epub 2016 Dec 6.